Staskin, D R <br/><br/>
Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions.  [electronic resource] 

 -  International journal of clinical practice  Jan 2008 
 - 27-38 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1368-5031 
<br/><br/><label>Standard No.: </label>10.1111/j.1742-1241.2007.01625.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Adult<br/>Aged<br/>Health Status Indicators<br/>Humans<br/>Male<br/>Mandelic Acids--administration & dosage<br/>Middle Aged<br/>Muscarinic Antagonists--administration & dosage<br/>Prospective Studies<br/>Prostatic Hyperplasia--complications<br/>Quality of Life<br/>Treatment Outcome<br/>Urinary Bladder, Overactive--drug therapy